DrugInfoSys

Dehydroemetine (HCl)

Drug #216

Dehydroemetine (HCl) is antiprotozoal drug. Dehydroemetine (HCl) is use in the treatment of amebic dysentery (infection of intestinal tract).

Primary Characteristics

It is of Synthetic origin and belongs to Emetine.

It is classified in Amebicides pharmacological group.

Molecular Weight: 551.6 · Solubility in Water: 1 in 30 · Non-proprietary name: Dehydroemetine (HCl).

Molecular structure of Dehydroemetine (HCl)

Pharmacokinetics

None recorded.

Advertisement

Indications

Dehydroemetine (HCl) is primarily indicated in conditions like Amoebic dysentry, Amoebic granulomata, Hepatic amoebiasis, Skin lesions.

Contraindications

Dehydroemetine (HCl) is contraindicated in conditions like Polyneuritis, Heart disease.

Dosage

Dehydroemetine (HCl)'s dosage details are as follows:

DoseSingle DoseFrequencyRouteInstructions
Adult Dosage
60 mg60 mgEvery 24hIMFor 4 to 6 days. It is a max daily dose. 0.5mg/kg is given for elderly or severly ill pateints.
Paediatric Dosage (20kg)
1 mg/kg1 mg/kgEvery 12hIntra MuscularFor not more than 10 Days
Neonatal Dosage (3kg)
0.6 mg/kg0.6 mg/kgEvery 12hIntra Muscular For not more than 10 Days

Drug Interactions

None recorded.

Side Effects

Dehydroemetine (HCl) produces potentially life-threatening effects which include Myocarditis . Careful monitoring is needed with proper medical management.

The signs and symptoms that are produced after acute overdosage of Dehydroemetine (HCl) are Myocardial toxicity.

Dehydroemetine (HCl) is known to cause more or less tolerable side effects which are usually transient. These include ECG changes, Giddiness, Headache, Local pain, Nausea, Pain at injection site, Vomiting .

Warnings / Precautions

Use with caution in congestive heart failure, recent myocardial infarction, cardiomyopathy, or primary muscular or neurological disorders. The safety of dehydroemetine in pregnancy has not been determined.

Available Brands

None recorded.

Storage Conditions

Dehydroemetine (HCl) should be stored .

Drug Classification

  1. 1.6.4.1Antiamebic & antigiardiasis drugs